These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 33544218)

  • 21. Sleep disturbances in Taiwanese patients with Parkinson's disease.
    Lin YY; Chen RS; Lu CS; Huang YZ; Weng YH; Yeh TH; Lin WY; Hung J
    Brain Behav; 2017 Oct; 7(10):e00806. PubMed ID: 29075566
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Levodopa Effect and Motor Function in Late Stage Parkinson's Disease.
    Rosqvist K; Horne M; Hagell P; Iwarsson S; Nilsson MH; Odin P
    J Parkinsons Dis; 2018; 8(1):59-70. PubMed ID: 29480220
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Shedding Light on Nocturnal Movements in Parkinson's Disease: Evidence from Wearable Technologies.
    Zampogna A; Manoni A; Asci F; Liguori C; Irrera F; Suppa A
    Sensors (Basel); 2020 Sep; 20(18):. PubMed ID: 32927816
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Nocturnal motor symptoms of Parkinson's disease and their treatment with the three-component drug levodopa/carbidopa/entacapone].
    Kulua TK; Fedorova NV; Popovkina OA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(9 Pt 2):45-50. PubMed ID: 22027607
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Natural history of motor symptoms in Parkinson's disease and the long-duration response to levodopa.
    Cilia R; Cereda E; Akpalu A; Sarfo FS; Cham M; Laryea R; Obese V; Oppon K; Del Sorbo F; Bonvegna S; Zecchinelli AL; Pezzoli G
    Brain; 2020 Aug; 143(8):2490-2501. PubMed ID: 32844196
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rotigotine for nocturnal hypokinesia in Parkinson's disease: Quantitative analysis of efficacy from a randomized, placebo-controlled trial using an axial inertial sensor.
    Bhidayasiri R; Sringean J; Chaiwong S; Anan C; Penkeaw N; Leaknok A; Boonpang K; Saksornchai K; Rattanachaisit W; Thanawattano C; Jagota P
    Parkinsonism Relat Disord; 2017 Nov; 44():124-128. PubMed ID: 28818560
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The impact of levodopa-carbidopa intestinal gel on health-related quality of life in Parkinson's disease].
    Kovács N; Aschermann Z; Ács P; Bosnyák E; Deli G; Janszky J; Komoly S
    Ideggyogy Sz; 2014 Jul; 67(7-8):245-50. PubMed ID: 25509365
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sleep problems affect quality of life in Parkinson's disease along disease progression.
    Liguori C; De Franco V; Cerroni R; Spanetta M; Mercuri NB; Stefani A; Pierantozzi M; Di Pucchio A
    Sleep Med; 2021 May; 81():307-311. PubMed ID: 33756280
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Zonisamide effects on sleep problems and depressive symptoms in Parkinson's disease.
    Suzuki K; Fujita H; Matsubara T; Haruyama Y; Kadowaki T; Funakoshi K; Watanabe Y; Hirata K
    Brain Behav; 2021 Mar; 11(3):e02026. PubMed ID: 33399276
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Does levodopa slow or hasten the rate of progression of Parkinson's disease?
    Fahn S;
    J Neurol; 2005 Oct; 252 Suppl 4():IV37-IV42. PubMed ID: 16222436
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tossing and Turning in Bed: Nocturnal Movements in Parkinson's Disease.
    Mirelman A; Hillel I; Rochester L; Del Din S; Bloem BR; Avanzino L; Nieuwboer A; Maidan I; Herman T; Thaler A; Gurevich T; Kestenbaum M; Orr-Urtreger A; Brys M; Cedarbaum JM; Giladi N; Hausdorff JM
    Mov Disord; 2020 Jun; 35(6):959-968. PubMed ID: 32080891
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of cutoff scores for the Parkinson's disease sleep scale-2.
    Suzuki K; Miyamoto T; Miyamoto M; Suzuki S; Numao A; Watanabe Y; Tatsumoto M; Sakuta H; Watanabe Y; Fujita H; Iwanami M; Sada T; Kadowaki T; Hashimoto K; Trenkwalder C; Hirata K
    Acta Neurol Scand; 2015 Jun; 131(6):426-30. PubMed ID: 25402773
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hypomimia in Parkinson's disease: an axial sign responsive to levodopa.
    Ricciardi L; De Angelis A; Marsili L; Faiman I; Pradhan P; Pereira EA; Edwards MJ; Morgante F; Bologna M
    Eur J Neurol; 2020 Dec; 27(12):2422-2429. PubMed ID: 32702196
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Achieving 24-hour control of Parkinson's disease symptoms: use of objective measures to improve nocturnal disability.
    Chaudhuri KR; Pal S; Bridgman K; Trenkwalder C
    Eur Neurol; 2001; 46 Suppl 1():3-10. PubMed ID: 11741097
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Levodopa increases speed of alternating movements in Parkinson's disease patients.
    Müller T; Peters S; Harati A
    J Neural Transm (Vienna); 2013 Feb; 120(2):309-13. PubMed ID: 22722446
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of Nocturnal Symptoms in Chinese Parkinson's Disease Patients Based on the PDSS-2 Scale: A Multicenter Cross-Sectional Study.
    Su W; Huang P; Ma X; Shang H; Ye Q; Cheng O; Chan P; Liu C; Liu W; Tang B; Wang L; Zhang B; Wang T; Shao M; Xie A; Chen X; Zhu X; Wang J; Tao E; Chen S; Chen H
    J Parkinsons Dis; 2023; 13(6):1061-1071. PubMed ID: 37522220
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intrajejunal levodopa infusion in advanced Parkinson's disease: long-term effects on motor and non-motor symptoms and impact on patient's and caregiver's quality of life.
    Fasano A; Ricciardi L; Lena F; Bentivoglio AR; Modugno N
    Eur Rev Med Pharmacol Sci; 2012 Jan; 16(1):79-89. PubMed ID: 22338551
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pain Correlates with Sleep Disturbances in Parkinson's Disease Patients.
    Fu YT; Mao CJ; Ma LJ; Zhang HJ; Wang Y; Li J; Huang JY; Liu JY; Liu CF
    Pain Pract; 2018 Jan; 18(1):29-37. PubMed ID: 28371220
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Sleep disturbances in patients with Parkinson's disease].
    Smiljković T
    Srp Arh Celok Lek; 2010; 138(5-6):274-8. PubMed ID: 20607967
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Subthalamic nucleus stimulation for Parkinson disease: benefits observed in levodopa-intolerant patients.
    Katayama Y; Kasai M; Oshima H; Fukaya C; Yamamoto T; Ogawa K; Mizutani T
    J Neurosurg; 2001 Aug; 95(2):213-21. PubMed ID: 11780890
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.